Progress in PET Imaging of Neuroinflammation Targeting COX-2 Enzyme
Open accessThe DOI matches its Crossref record; 61 of the 64 references it cites were found in a registry or an index.
Abstract
Neuroinflammation and cyclooxygenase-2 (COX-2) upregulation are associated with the pathogenesis of degenerative brain diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), epilepsy, and a response to traumatic brain injury (TBI) or stroke. COX-2 is also induced in acute pain, depression, schizophrenia, various cancers, arthritis and in acute allograft rejection. Positron emission tomography (PET) imaging allows for the direct measurement of in vivo COX-2 upregulation and thereby enables disease staging, therapy evaluation and aid quantifying target occupancy of novel nonsteroidal anti-inflammatory drugs or NSAIDs. Thus far, no clinically useful radioligand is established for monitoring COX-2 induction in brain diseases due to the delay in identifying qualified COX-2-selective inhibitors entering the brain. This review examines radiolabeled COX-2 inhibitors reported in the past decade and identifies the most promising radioligands for development as clinically useful PET radioligands. Among the radioligands reported so far, the three tracers that show potential for clinical translation are, [11CTMI], [11C]MC1 and [18F]MTP. These radioligands demonstrated BBB permeablity and in vivo binding to constitutive COX-2 in the brain or induced COX-2 during neuroinflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 (a) MRI and summed (0–120 min) PET images of [11C]TMI in healthy baboon: (b) total volume of distribution (VTs) in baboon brain, baseline and blocking, estimated using a one-tissue compartment (1TC), Logan plot and likelihood estimation in graphical analysis (LEGA) methods. CIN: cingulate cortex; CER: cerebellum; FRT: frontal cortex; HIP: hippocampus; ORB: orbital cortex; THA: thalamus.](https://figures.cochat.ai/paper-figures/cd3e7c4c65354662a5a856375afcd71d/progress-in-pet-imaging-of-neuroinflammation-targeting-cox-2-enzyme-figure-2.jpg)
![Figure 3 Representative microPET images of [18F]MTP in PBS- and LPS-administered mice (a); TACs of [18F]MTP in PBS- (green) and LPS (red)-treated mice (b).](https://figures.cochat.ai/paper-figures/10112ee9e5ba45278195dd669ec94cc3/progress-in-pet-imaging-of-neuroinflammation-targeting-cox-2-enzyme-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Preclinical studies confirm that chronic unpredictable stress increases the uptake of PET radioligands targeting the COX-2 enzyme and cerebral PGE-2 concentrations in susceptible compared to resilient mice (160).”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [160]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cyclooxygenases: Structural, cellular, and molecular biology
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.145 · Cited by 2,925 · cited 2×
“COX-1 and COX-2 show >60% homology between humans and rodents [2].”
BackgroundCyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Neuroinflammation: The Devil Is in the Details
DiSabato, D. J., Quan, N., & Godbout, J. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13607 · Cited by 1,640 · cited 1×
“The degree of neuroinflammation depends on the context, duration and course of the primary stimulus [33].”
BackgroundCyclooxygenase-2 (COX-2) in Inflammatory and Degenerative Brain Diseases
Minghetti, L. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.9.901 · Cited by 779
Encyclopedia of Clinical Neuropsychology
(2011) · Springer eBooks · doi:10.1007/978-0-387-79948-3 · Cited by 726
Cyclooxygenases: structural and functional insights
Rouzer, C. A., & Marnett, L. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800042-jlr200 · Cited by 688
Banks, W. A., Gray, A. M., Erickson, M. A., Salameh, T. S., Damodarasamy, M., Sheibani, N., Meabon, J. S., Wing, E. E., Morofuji, Y., Cook, D. G., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0434-1 · Cited by 636 · cited 1×
“v injection has shown to be optimum for inducing neuroinflammation without BBB compromise [42].”
BackgroundStructural and Functional Basis of Cyclooxygenase Inhibition
Blobaum, A. L., & Marnett, L. J. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0613166 · Cited by 550
Protective effects of NSAIDs on the development of Alzheimer disease
Vlad, S. C., Miller, D. R., Kowall, N. W., & Felson, D. T. (2008) · Neurology · doi:10.1212/01.wnl.0000311269.57716.63 · Cited by 535 · cited 1×
“COX-2 induction is also reported in psychiatric disorders such as major depressive disorders (MDD) and schizophrenia [22,23].”
Background
Research works printed but not linked: 2
- Pal, 2018, Incidence and Prevalence of Major Neurologic Disorders, Neurology, 43, 24
- Cortes, 2015, Synthesis of PET radioligands as potential probes for imaging COX-2 in neuroinflammation, J. Nucl. Med., 56, 1092
Cited by
Hassamal, S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1130989 · Cited by 578
Arachidonic acid metabolism in health and disease
Zhang, Y., Liu, Y., Sun, J., Zhang, W., Guo, Z., & Ma, Q. (2023) · MedComm · doi:10.1002/mco2.363 · Cited by 295
The Interplay between Ferroptosis and Neuroinflammation in Central Neurological Disorders
Xu, Y., Jia, B., Li, J., Li, Q., & Luo, C. (2024) · Antioxidants · doi:10.3390/antiox13040395 · Cited by 113
Zhang, L., Li, M., Wang, W., Yu, W., Liu, H., Wang, K., Chang, M., Deng, C., Ji, Y., Shen, Y., et al. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115186 · Cited by 79
Traumatic Brain Injury and Early Onset Dementia in Post 9-11 Veterans
Kennedy, E., Panahi, S., Stewart, I. J., Tate, D. F., Wilde, E. A., Kenney, K., Werner, J. K., Gill, J., Diaz-Arrastia, R. R., Amuan, M. E., et al. (2022) · Brain Injury · doi:10.1080/02699052.2022.2033846 · Cited by 45
PET imaging of neuroinflammation: any credible alternatives to TSPO yet?
Chauveau, F., Winkeler, A., Chalon, S., Boutin, H., & Becker, G. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02656-9 · Cited by 45
Biology of cyclooxygenase-2: An application in depression therapeutics
He, Y., Han, Y., Liao, X., Zou, M., & Wang, Y. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1037588 · Cited by 45
Zhou, J., Zeng, F., Cheng, S., Dong, X., Jiang, N., Zhang, X., Tang, C., He, W., Chen, Y., Sun, N. L., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14153 · Cited by 40
Xie, T., Pei, Y., Shan, P., Xiao, Q., Fei, Z., Huang, L., & Wang, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.909222 · Cited by 39
Connexin 43: An Interface Connecting Neuroinflammation to Depression
Jiang, H., Zhang, Y., Wang, Z., & Chen, N. (2023) · Molecules · doi:10.3390/molecules28041820 · Cited by 38
Research progress and prospect of MAPK signaling pathway in knee osteoarthritis
Fan, Q., Zhao, M., Zhang, X.-D., Chu, T.-Y., Kou, Z.-X., & Zhao, Q. (2025) · European Journal of Orthopaedic Surgery & Traumatology · doi:10.1007/s00590-025-04261-0 · Cited by 37
Pizarro-Galleguillos, B., Kunert, L., Brüggemann, N., & Prasuhn, J. (2023) · Antioxidants · doi:10.3390/antiox12071411 · Cited by 35
Strekalova, T. V., Pavlov, D., Трофимов, А. Н., Anthony, D. C., Svistunov, A. A., Proshin, A. T., Umriukhin, A., Lyundup, A. V., Lesch, K., & Cespuglio, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042061 · Cited by 32
Khalil, H. M. A., Henafy, H. M. A. E., Khalil, I. A. H., Bakr, A. F., Fahmy, M. I., Younis, N. S., & El‐Shiekh, R. A. (2023) · Toxics · doi:10.3390/toxics11020159 · Cited by 31
Righi, N., Deghima, A., Daoud, I., Fernandes, P. A. R., Baali, F., Boumerfeg, S., Baghiani, A., Coimbra, M. A., & Coelho, E. (2023) · South African Journal of Botany · doi:10.1016/j.sajb.2023.03.050 · Cited by 31
Human Glial Cells as Innovative Targets for the Therapy of Central Nervous System Pathologies
Magni, G., Riboldi, B., & Ceruti, S. (2024) · Cells · doi:10.3390/cells13070606 · Cited by 30
Li, T., Zheng, J., Xia, M., Zhu, H., Song, X., Zhou, Y., Yin, C., Yu, Z., Hu, E., Cai, Z., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202419613 · Cited by 29
Kaempferol Improves Breast Cancer-Related Depression through the COX-2/PGE2 Pathway
Zhu, Q., Han, Y., He, Y., Fu, Y., Yang, H., Chen, Y., & Shi, Y. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2811311 · Cited by 28
Pei, Y., Chen, S., Zhou, F., Xie, T., & Cao, H. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1146660 · Cited by 25
Zhang, B., Zhao, Y., Guo, K., Tian, H., Cao, W. F., Wang, R. L., Chen, Y., Chen, D., Zheng, H., Gao, B., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10459 · Cited by 24
Shen, Y., Li, X., Wang, H., Wang, Y., Tao, L., Wang, P., & Zhang, H. (2023) · Toxicology · doi:10.1016/j.tox.2023.153678 · Cited by 22
Yang, X., Ma, Z., Lian, P., Wu, Y., Liu, K., Zhang, Z., Tang, Z., Xu, Y. C., & Cao, X. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00926-z · Cited by 22
Studzińska-Sroka, E., Bulicz, M., Henkel, M., Rosiak, N., Paczkowska‐Walendowska, M., Szwajgier, D., Baranowska‐Wójcik, E., Korybalska, K., & Cielecka‐Piontek, J. (2023) · Molecules · doi:10.3390/molecules29010233 · Cited by 22
da Silva, D. M. A., Lopes, I. S., Oliveira, J. V. S., Júnior, M. A. S., Rebouças, M. D. O., Valentim, J. T., Vale, L. D. C., Capibaribe, V. C. C., de Carvalho, M. A. J., de Aquino, P. É. A., et al. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173778 · Cited by 20
Jain, S., Bhushan, B., Mishra, A. K., & Singh, R. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106413 · Cited by 20
Long, X., He, K., Zhang, M., Li, M., Wang, Z., Wang, C., Dong, X., Shao, J., Gan, L., Hu, X., et al. (2023) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2023.109693 · Cited by 20
Acetylsalicylic Acid and Mood Disorders: A Systematic Review
Dominiak, M., Gędek, A., Sikorska, M., Mierzejewski, P., Wojnar, M., & Antosik-Wójcińska, A. Z. (2022) · Pharmaceuticals · doi:10.3390/ph16010067 · Cited by 17
Advanced brain imaging for the diagnosis of Alzheimer disease
Wang, Y.-T. T., Rosa‐Neto, P., & Gauthier, S. G. (2023) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001198 · Cited by 17
Arab, H. H., Khames, A., Mohammad, M. K., Alsufyani, S. E., Ashour, A. M., El‐Sheikh, A. A. K., Darwish, H. W., & Gad, A. M. (2023) · Pharmaceuticals · doi:10.3390/ph16060848 · Cited by 16
Positron Emission Tomography of Neuroimmune Responses in Humans: Insights and Intricacies
Raval, N. R., Wetherill, R. R., Wiers, C. E., Dubroff, J. G., & Hillmer, A. T. (2022) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2022.08.008 · Cited by 15
Chand, G. B., Jiang, H., Miller, J. P., Rhodes, C. H., Tu, Z., & Wong, D. F. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.827981 · Cited by 13
Ma, H., Huang, H., Li, C., Li, S., Gan, J., Lian, C.-R., & Ling, Y. (2024) · npj Systems Biology and Applications · doi:10.1038/s41540-024-00329-5 · Cited by 12
Salahuddin, H. S., Attaullah, S., Shah, S. A., Khan, S., Zahid, M., Ullah, M., Khayyam, Salahuddin, S., Gul, S., & Alsugoor, M. H. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.101702 · Cited by 11
Zeng, M., & Xu, W. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04274-6 · Cited by 10
Advances in PET imaging of ischemic stroke
Orhii, P., Haque, M. E., Fujita, M., & Selvaraj, S. (2023) · Frontiers in Stroke · doi:10.3389/fstro.2022.1093386 · Cited by 9
A Fast-Binding, Functionally Reversible, COX‑2 Radiotracer for CNS PET Imaging
Placzek, M. S., Wilton, D. K., Weïwer, M., Manter, M. A., Reid, S. E., Meyer, C. J., Campbell, A. J., Bajrami, B., Bigot, A., Bricault, S., et al. (2024) · ACS Central Science · doi:10.1021/acscentsci.3c01564 · Cited by 10
The protective effects of orexin B in neuropathic pain by suppressing inflammatory response
Zhu, Z., Chen, G., He, J., & Xu, Y. (2024) · Neuropeptides · doi:10.1016/j.npep.2024.102458 · Cited by 9
Inflammatory Bridges: Interconnections Between Alzheimer’s Disease and Bone Health
Li, H., Wang, W., Zhang, L., Wang, T., Liu, J., Wu, J., Ni, Q., Sun, B., & Sun, J. J. (2025) · Aging and Disease · doi:10.14336/ad.2025.10319 · Cited by 9
Giarratana, A. O. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1637243 · Cited by 10
Shukuri, M., Mawatari, A., Takatani, S., Tahara, T., Inoue, M., Arakaki, W., Ohno, M., Doi, H., & Onoe, H. (2022) · PubMed · doi:10.2967/jnumed.121.263713 · Cited by 9
Lemm, S., Köhler, S., Wodtke, R., Jung, F., Küpper, J., Pietzsch, J., & Laube, M. (2022) · Cells · doi:10.3390/cells11152447 · Cited by 9
Potential drugs for the treatment of Alzheimer’s disease
Montero-Cosme, T. G., Pascual-Mathey, L. I., Hernández‐Aguilar, M. E., Herrera‐Covarrubias, D., Rojas-Durán, F., & Aranda-Abreu, G. E. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00481-5 · Cited by 8
Ferreira, T., Faustino‐Rocha, A. I., Gaspar, V. M., Medeiros, R., Mano, J. F., & Oliveira, P. A. (2024) · Veterinary World · doi:10.14202/vetworld.2024.1052-1072 · Cited by 8
Ваулина, Д. Д., Стосман, К. И., Сивак, К. В., Александров, А. Г., Viktorov, N. B., Kuzmich, N. N., Kiseleva, M., Kuznetsova, O. F., & Gomzina, N. A. (2021) · Molecules · doi:10.3390/molecules26216630 · Cited by 8
Alshammari, A. A. A., Arfeen, M., Alkhamiss, A. S., Alwesmi, M. B., & Mani, V. (2025) · Food and Chemical Toxicology · doi:10.1016/j.fct.2025.115448 · Cited by 7
Tyler, S. E. B., & Tyler, L. D. K. (2023) · Brain Disorders · doi:10.1016/j.dscb.2023.100094 · Cited by 7
Kaur, A., Rehman, H. M., Mishra, V. K., Kaur, G., Kaur, M., Okla, M. K., Shah, M., & Bansal, M. (2025) · RSC Medicinal Chemistry · doi:10.1039/d4md00751d · Cited by 6
Fluorine-18 Labelled Radioligands for PET Imaging of Cyclooxygenase-2
Kaur, J. P., Bhardwaj, A., & Wuest, F. R. (2022) · Molecules · doi:10.3390/molecules27123722 · Cited by 6
Up-and-coming Radiotracers for Imaging Pain Generators
van der Heijden, R. A., & Biswal, S. (2023) · Seminars in Musculoskeletal Radiology · doi:10.1055/s-0043-1775745 · Cited by 6
Qin, Y., Li, J., Chen, F., Wang, L., Bo, T., Zhai, X., & Lu, Y. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01733-4 · Cited by 5
Evaluation of advanced, pathophysiologic new targets for imaging of CNS
Singh, P., Singh, D., Srivastava, P., Mishra, G., & Tiwari, A. K. (2023) · Drug Development Research · doi:10.1002/ddr.22040 · Cited by 5
Morgan, G. C., Gregory, A., Tang, C., Hwang, S. H., Border, J. J., Xu, J., Liu, Y., Bai, S., Lee, T. J., Cantwell, C., et al. (2026) · GeroScience · doi:10.1007/s11357-026-02140-y · Cited by 4
Li, Q., Hung, I., Bai, K., & Wang, T. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.1043842 · Cited by 4
Sujatha, S. (2024) · Journal of Electrical Systems · doi:10.52783/jes.2711 · Cited by 4
Alshammari, A. A. A., Alkhamiss, A. S., Arfeen, M., Alawaji, R., Alwesmi, M. B., & Mani, V. (2026) · Life · doi:10.3390/life16030491 · Cited by 3
Nadalin, S., Ljoka, I., Savić, A., Silić, A., Peitl, V., Karlović, D., Vilibić, M., Zatković, L., & Buretić‐Tomljanović, A. (2025) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2025.102665 · Cited by 3
Shah, S. S., Shetty, A. J., Johnston, D. T., Hanan, C. L., Oreilly, B. T., Skibber, M. A., Massoud, A. T., Zhu, B., Sevick-Muraca, E. M., Juranek, J. J., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1587222 · Cited by 3
Accelerometer-based head impact detection in soccer - Where are we?
Deju, B., Afzal, H., Basnyat, S., Dali, A., Scott, K. E. J., DeLancey, R. L., & Chopra, N. (2023) · Health Sciences Review · doi:10.1016/j.hsr.2023.100141 · Cited by 3
Imaging the neuroinflammatory landscape: COX enzyme mapping with PET
Asghari, A., Seyedi, D., Kazemi, H. S., Abbasian, V., Sadatmadani, S.-F., Bahmanziari, M., Asadian, Z., Salehkheil, S., Mahdavipour, A., Habibzadeh, E., et al. (2025) · Clinical and Translational Imaging · doi:10.1007/s40336-025-00710-2 · Cited by 2
The utility of PET imaging in the diagnosis and management of psychosis: a brief review
Rigney, G. H., Ayubcha, C., Werner, T. J., Alavi, A. A., & Revheim, M.-E. R. (2021) · Clinical and Translational Imaging · doi:10.1007/s40336-021-00466-5 · Cited by 2
Research Progress on Anti-Inflammatory Mechanisms of Compounds from Gentiaceae Plants
彭, 学. (2024) · Pharmacy Information · doi:10.12677/pi.2024.131004 · Cited by 2
Sujatha, T. (2024) · Journal of Electrical Systems · doi:10.52783/jes.1995 · Cited by 2
Elhadidy, M. E., Taha, M. S., Salem, A. A. M., & Hammoud, G. M. (2025) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-025-01335-1 · Cited by 1
APOE Polymorphism and Brain Imaging
Obenaus, A., & Territo, P. R. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_69-1 · Cited by 1
Waheed, R., Mostafa, Z., Emad, M., Darwish, S. S., Purgatorio, R., Miniero, D. V., Palma, A. D., Cheng, T., Wang, T., Chen, Y., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118261 · Cited by 1
Radiolabeled para-I-nimesulide: an unexpected tracer for imaging peripheral inflammation
Yamamoto, Y., Imai, K., Saito, Y., & Yamamoto, F. (2026) · Frontiers in Nuclear Medicine · doi:10.3389/fnume.2025.1720380 · Cited by 1
Blunted Niacin Skin Flushing Response in Mood Disorders: A Meta‐Analysis of Case–Control Studies
Wang, Q., Wang, J., Hu, X., Gao, Y., Li, S., Wang, T., Wang, D., & Wan, C. (2026) · Depression and Anxiety · doi:10.1155/da/1967324 · Cited by 1
Трофимов, А. Н. (2024) · Research Publications (Maastricht University) · doi:10.26481/dis.20240205at · Cited by 1
Neuroinflammation Imaging in Neurodegenerative Diseases
Hammoud, D. A., & Herscovitch, P. (2023) · Springer eBooks · doi:10.1007/978-3-031-35098-6_9
Jin, C., & Zhang, H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95223-1.00028-x
Wang, S., Xu, X., & Liu, L. (2024) · Chinese Medicine Research and Development · doi:10.57237/j.cmrd.2024.02.002
Azimi, S. M., Elhaie, M., Abedi, I., & Salehi, H. (2025) · Advanced Biomedical Research · doi:10.4103/abr.abr_224_24
Mini-review and situation report on the role and usefulness of nuclear medicine imaging for malaria
Duvenhage, J., Zeevaart, J. R., Sathekge, M. M., & Ebenhan, T. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07443-4
De Grandpré, S. (2023) · PolyPublie (École Polytechnique de Montréal)
Asadi, F., & Jebali, A. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5897662
Rodrigues, T. A. [. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Piperine's activity in modulating inflammatory mediators in head and neck cancer cells
Gusson-Zanetoni, J. P. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Yun, T., Xiao, Y.-Y., Gong, Y., Lai, Y., Huang, S. J., Ma, Y., Zeng, Y., Zhang, L., & Deng, C. (2026) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2508.08046
Faadila, A., Utami, W., & Aisyah, A. (2026) · Jurnal Kimia Sains dan Aplikasi · doi:10.14710/jksa.29.2.132-148
Cai, L., He, Y., Li, X., Fang, H., Ma, Y., Shi, G., Zhang, L., & Lin, C. (2026) · Journal of Oleo Science · doi:10.5650/jos.ess26002
The emerging landscape of circulatory biomarkers in Alzheimer’s disease
Kumari, S., Rais, A., Ashar, M. S., Singh, A. K., Anwar, M., Pradhan, R., & Dey, S. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.08.008
Jia, N., Tang, C., Huang, H., & Wang, J. (2026) · Brain Network Disorders · doi:10.1016/j.bnd.2026.08.001
Ullah, K., Shah, S. W. A., Hussain, H., Ullah, A., Khan, F. A., Khan, N. M., Khan, A., Khan, S. U., Zahoor, M., Alotaibi, A., et al. (2026) · Future Medicinal Chemistry · doi:10.1080/17568919.2026.2754119
Xie, T., Pei, Y., Shan, P., Xiao, Q., Zhou, F., Huang, L., & Wang, S. (2022) · doi:10.3389/fnagi.2022.909222.s007
Metadata
- Authors
- Prabhakaran, J., Molotkov, A., Mintz, A., & Mann, J. J.
- Affiliations
- Columbia University Irving Medical Center (US)
- Corresponding author
- Prabhakaran, Jaya
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2021-05-27
- Volume
- 26
- Issue
- 11
- Pages
- 3208
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC8198977
- OpenAlex
- W3165497367
- Cited by
- 74
- References
- 64
- Citations by year
- 2026: 6 · 2025: 17 · 2024: 15 · 2023: 22 · 2022: 12 · 2021: 2
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (R01AG070042)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- neuroinflammation, cyclooxygenase-2, PET radiotracer, COX-2 inhibitors, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, traumatic brain injury, stroke, nonsteroidal anti-inflammatory drugs, target occupancy
- MeSH terms
- Celecoxib, Animals, Anti-Inflammatory Agents, Blood-Brain Barrier, Brain, Central Nervous System Diseases, Chemistry, Pharmaceutical, Female, Humans, Inflammation, Kinetics, Ligands, Magnetic Resonance Imaging, Male, Papio, Permeability, Positron-Emission Tomography, Mice, Rats, Cyclooxygenase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.